Pierre A. Geoffroy, MD, PhD

Département de Psychiatrie et d’Addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hopital Bichat—Claude Bernard, Paris, France; Université Paris Cité, NeuroDiderot, Inserm, FHU I2-D2, Paris, France; Centre ChronoS, GHU Paris—Psychiatry & Neurosciences, Paris, France.; Corresponding Author: Pierre A. Geoffroy, MD, PhD, Department of Psychiatry and Addictive Medicine, University Hospital Bichat-Claude Bernard, 46 rue Henri Huchard, Paris 75018, France ([email protected]).

JCP
Sleep Alterations as Proximal Markers for Suicide Risk
JCP
Dual Orexin Receptor Antagonists and Suicide Risk
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
JCP
Sleep Complaints and Risk of Psychiatric Disorders
JCP
Bad Dreams and Nightmares Preceding Suicidal Behaviors